A seven-gene methylation markers panel: An epigenetic predictor of neoadjuvant chemotherapy sensitivity in triple-negative breast cancer

被引：0
|
作者：
Sigin, V. O. [1 ]
Kalinkin, A. I. [1 ]
Ignatova, E. [2 ]
Sycheva, A. V. [1 ]
Vinogradov, I. I. [3 ]
Vinogradov, M. I. [4 ]
Vinogradov, I. Y.
Zaletaev, D. V. [5 ]
Strelnikov, V. V. [1 ]
Tanas, A. S. [1 ]
机构：
[1] Res Ctr Med Genet, Epigenet, Fed State Budgetary Inst, Moscow, Russia
[2] FSBI NN Blokhin Russian Canc Res Ctr, Clin Pharmacol & Chemotherapy, Moscow, Russia
[3] Ryazan Reg Clin Oncol Dispensary, Pathol & Anat, Ryazan, Russia
[4] Ryazan State Med Univ, Ryazan, Russia
[5] IM Sechenov First Moscow State Med Univ, Fed State Autonomous Educ Inst Higher Educ, Sechenov Univ, Med Genet Lab,Minist Hlth Russian Federat, Moscow, Russia
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
10.1093/annonc/mdz413.062
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
58P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Development of DNA methylation markers panels for neoadjuvant chemotherapy response prediction in triple-negative breast cancer
    Sigin, V. O.
    Kalinkin, A. I.
    Ignatova, E.
    Chesnokova, G.
    Vinogradov, I. Y.
    Vinogradov, I. I.
    Vinogradov, M. I.
    Strelnikov, V. V.
    Zaletaev, D. V.
    Tanas, A. S.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1225 - S1225
  • [2] A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Pineda, Begona
    Diaz-Lagares, Angel
    Alejandro Perez-Fidalgo, Jose
    Burgues, Octavio
    Gonzalez-Barrallo, Ines
    Crujeiras, Ana B.
    Sandoval, Juan
    Esteller, Manel
    Lluch, Ana
    Eroles, Pilar
    [J]. CLINICAL EPIGENETICS, 2019, 11 (1)
  • [3] A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Begoña Pineda
    Angel Diaz-Lagares
    José Alejandro Pérez-Fidalgo
    Octavio Burgués
    Inés González-Barrallo
    Ana B. Crujeiras
    Juan Sandoval
    Manel Esteller
    Ana Lluch
    Pilar Eroles
    [J]. Clinical Epigenetics, 2019, 11
  • [4] THE GENE EXPRESSION PROFILE OF TRIPLE-NEGATIVE BREAST CANCER AFTER NEOADJUVANT CHEMOTHERAPY
    Philipovskiy, A.
    Gaur, S.
    Chambers, K.
    Gamez, R.
    McCallum, R.
    Kirken, R.
    Aguilera, R.
    Roy, S.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 440 - 440
  • [5] A novel seven-gene signature predicts prognosis in early-stage triple-negative breast cancer
    Ren, Y.
    Jiang, Y.
    Zuo, W.
    Xu, X.
    Jin, X.
    Ma, D.
    Shao, Z.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [6] Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review
    van den Ende, Nadine S. S.
    Nguyen, Anh H. H.
    Jager, Agnes
    Kok, Marleen
    Debets, Reno
    van Deurzen, Carolien H. M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [7] Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer
    Stover, Daniel G.
    Bell, Caitlin F.
    Tolaney, Sara M.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 6 - 12
  • [8] TOPK: A new predictor of the therapeutic response to neoadjuvant chemotherapy and prognosis in triple-negative breast cancer
    Wang, Kaijing
    Chai, Jia
    Xu, Junpeng
    Wei, Jie
    Li, Peifeng
    Liu, Yixiong
    Ma, Jing
    Xu, Tianqi
    Zhao, Danhui
    Yu, Kangjie
    Fan, Linni
    Yan, Qingguo
    Guo, Shuangping
    Li, Mingyang
    Wang, Zhe
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2021, 226
  • [9] Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy
    Marra, Antonio
    Curigliano, Giuseppe
    [J]. CANCER JOURNAL, 2021, 27 (01): : 41 - 49
  • [10] A seven-gene CpG-island methylation panel predicts breast cancer progression
    Li, Yan
    Melnikov, Anatoliy A.
    Levenson, Victor
    Guerra, Emanuela
    Simeone, Pasquale
    Alberti, Saverio
    Deng, Youping
    [J]. BMC CANCER, 2015, 15
12345